Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meiqi Yi

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Cell Death & Disease|November 9, 2022
Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibilityYingying Ma, Meiqi Yi, Weixuan Wang, et al.
Developmental Neuroscience|October 24, 2025
Genetic Characterization of 128 Chinese Individuals with Neurodevelopmental Disorders via Whole-Exome SequencingYayun Qin, Huang Cao, Lijun Liu, et al.
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Genetic insights and clinical outcomes in fetal ventriculomegaly: A retrospective analysisLing Zeng, Meiqi Yi, Ting Wang, et al.
International Journal of Pharmaceutics|October 29, 2025
Mitigating polysorbate degradation-induced visible particle formation in an antibody formulation: From root cause identification to strategic solutionTing Hu, Meiqi Yi, Zheng Zhang, et al.
Clinical Biochemistry|January 7, 2023
Identification of a novel 10.3 kb deletion causing α<sup>0</sup>-thalassemia by third-generation sequencing: Pedigree analysis and genetic diagnosisRunhong Xu, Hui Li, Song Yi, et al.
Chemical Science|April 19, 2019
Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blockingLin Zhang, Hao Shen, Yiyi Gong, et al.
Mabs|May 25, 2023
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activityMeiqi Yi, Jian Sun, Hanzi Sun, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cell Death & Disease|November 9, 2022
Oxidative degradation of dihydrofolate reductase increases CD38-mediated ferroptosis susceptibilityYingying Ma, Meiqi Yi, Weixuan Wang, et al.
Developmental Neuroscience|October 24, 2025
Genetic Characterization of 128 Chinese Individuals with Neurodevelopmental Disorders via Whole-Exome SequencingYayun Qin, Huang Cao, Lijun Liu, et al.
Taiwanese Journal of Obstetrics & Gynecology|September 11, 2025
Genetic insights and clinical outcomes in fetal ventriculomegaly: A retrospective analysisLing Zeng, Meiqi Yi, Ting Wang, et al.
International Journal of Pharmaceutics|October 29, 2025
Mitigating polysorbate degradation-induced visible particle formation in an antibody formulation: From root cause identification to strategic solutionTing Hu, Meiqi Yi, Zheng Zhang, et al.
Clinical Biochemistry|January 7, 2023
Identification of a novel 10.3 kb deletion causing α<sup>0</sup>-thalassemia by third-generation sequencing: Pedigree analysis and genetic diagnosisRunhong Xu, Hui Li, Song Yi, et al.
Chemical Science|April 19, 2019
Development of a dual-functional conjugate of antigenic peptide and Fc-III mimetics (DCAF) for targeted antibody blockingLin Zhang, Hao Shen, Yiyi Gong, et al.
Mabs|May 25, 2023
Identification and characterization of an unexpected isomerization motif in CDRH2 that affects antibody activityMeiqi Yi, Jian Sun, Hanzi Sun, et al.
Mabs|December 14, 2023
Accelerating the speed of innovative anti-tumor drugs to first-in-human trials incorporating key de-risk strategiesYuqi Wang, Quan Quan, Camille Gleason, et al.
Pageof 2